Strategic Advisor to the Cannabinoid Research and Development Group (CRDG) at the Centre for Medicinal Cannabis (CMC). - The Centre for Medicinal Cannabis (CMC).
George Freeman · Register #754 to #757
Published snapshots: 25 Nov 2024 → 9 Dec 2024
Source-field comparison
5 field differences
Is Until Further Notice
changedBefore
False
After
True
Payer Nature Of Business
changedBefore
CMC is a not for profit industry membership organisation focused on clinical research and development of cannabinoid medicines. The Centre has three platforms with the following trading names: The Association for the Cannabinoid Industry (ACI), which relates to cannabinoids as a food ingredient; The Medical Cannabis Alliance (MCA), which is for Cannabis Based Medical Products; and Cannabinoid Research and Development Group (CRDG).
After
CMC is a not for profit industry membership organisation focused on clinical research and development of cannabinoid medicines. The Centre has three platforms with the following trading names: The Association for the Cannabinoid Industry (ACI), which relates to cannabinoids as a food ingredient; The Medical Cannabis Alliance (MCA), which is for Cannabis Based Medical Products; and Cannabinoid Research and Development Group (CRDG)
Payer Public Address
changedBefore
10 Queen Street Place, London, England, EC4R 1BE.
After
10 Queen Street Place, London, England EC4R 1BE.
Update history
addedBefore
Not present
After
2024-12-03
End Date
addedBefore
Not present
After
2024-11-30
These labels report a difference between two published registers. They do not explain why the filing changed or imply wrongdoing, influence or causation.